Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.

Buzón-Martín L, Bernardino JI, Galindo Puerto MJ, Martín-Torres J, Alemán Valls MR, Torralba González de Suso M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello Úbeda A, Pedrero-Tomé R, Crusells Canales MJ, Calzado Isbert S, Aguilera García M, Hidalgo Tenorio C, Morano L, Vinuesa García D, de Andrés David C, Bernal Morell E, Martínez Álvarez RM, Cabello Clotet N, Tiraboschi J, Gimeno García A, Vivancos MJ, Troya J, the RELATIVITY Cohort Group

Open source

DOI: 10.1097/qad.0000000000004388
Published: 2026 Apr 1
Container: AIDS (London, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/qad.0000000000004388,
  title = {Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.},
  author = {Buzón-Martín L and Bernardino JI and Galindo Puerto MJ and Martín-Torres J and Alemán Valls MR and Torralba González de Suso M and Díaz de Santiago A and Fanjul F and Rodríguez A and Cabello Úbeda A and Pedrero-Tomé R and Crusells Canales MJ and Calzado Isbert S and Aguilera García M and Hidalgo Tenorio C and Morano L and Vinuesa García D and de Andrés David C and Bernal Morell E and Martínez Álvarez RM and Cabello Clotet N and Tiraboschi J and Gimeno García A and Vivancos MJ and Troya J and the RELATIVITY Cohort Group},
  year = {2026},
  journal = {AIDS (London, England)},
  doi = {10.1097/qad.0000000000004388},
  url = {https://doi.org/10.1097/qad.0000000000004388}
}

RIS

TY  - JOUR
TI  - Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.
AU  - Buzón-Martín L
AU  - Bernardino JI
AU  - Galindo Puerto MJ
AU  - Martín-Torres J
AU  - Alemán Valls MR
AU  - Torralba González de Suso M
AU  - Díaz de Santiago A
AU  - Fanjul F
AU  - Rodríguez A
AU  - Cabello Úbeda A
AU  - Pedrero-Tomé R
AU  - Crusells Canales MJ
AU  - Calzado Isbert S
AU  - Aguilera García M
AU  - Hidalgo Tenorio C
AU  - Morano L
AU  - Vinuesa García D
AU  - de Andrés David C
AU  - Bernal Morell E
AU  - Martínez Álvarez RM
AU  - Cabello Clotet N
AU  - Tiraboschi J
AU  - Gimeno García A
AU  - Vivancos MJ
AU  - Troya J
AU  - the RELATIVITY Cohort Group
PY  - 2026
JO  - AIDS (London, England)
DO  - 10.1097/qad.0000000000004388
UR  - https://doi.org/10.1097/qad.0000000000004388
ER  -

APA

L, B., JI, B., MJ, G. P., J, M., MR, A. V., M, T. G. D. S., A, D. D. S., F, F., A, R., A, C. Ú., R, P., MJ, C. C., S, C. I., M, A. G., C, H. T., L, M., D, V. G., C, D. A. D., E, B. M., RM, M. Á., N, C. C., J, T., A, G. G., MJ, V., J, T., & Group, T. R. C. (2026). Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.. AIDS (London, England). https://doi.org/10.1097/qad.0000000000004388

Source records

pubmed · retrieved 2026-09-27T00:06:11.069Z
europe-pmc · retrieved 2026-09-27T00:06:11.075Z